increase font sizeEnlarge text size


A knowledge-based enterprise since formation, Interpath has invested heavily in research and development of their joint nutraceutical products, which have resulted in ground breaking results in the research of cellular and tissue inflammation including degenerative joint disease (DJD).


Interpath has utilised the latest molecular and cellular biology techniques and technologies, with in-vivo and in-vitro studies providing unequivocal understanding of the science behind their signature products.   



4CYTE Equine launched in Aus
4CYTE Equine has being launched in Australia, and there has being a travelling road show introducing this exciting new product to Equine Vets.
More News...

Interpath Global Positioning


All Content © 2014 Interpath - Website by CeCC  | Intellectual Property | Sitemap